GMAB GENMAB A/S: institutional ownership and insider trading
317 funds reported holding $2.99B of GENMAB A/S in their latest 13F filings; in Q2 2026 funds net bought $684M, with 44 new positions and 30 funds selling out.
Famous investors holding GMAB
- Renaissance Technologies (Renaissance Technologies): $96.6M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $96.3M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $77.8M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $25.0M, 0.0% of the portfolio
Largest institutional holders of GMAB
- Paradigm Biocapital Advisors LP — $361M
- Orbis Allan Gray Ltd — $312M
- Deep Track Capital, LP — $238M
- ALLIANCEBERNSTEIN L.P. — $232M
- DEERFIELD MANAGEMENT COMPANY, L.P. — $189M
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — $137M
- BlackRock, Inc. (BLK) — $128M
- Sofinnova Investments, Inc. — $111M
- RENAISSANCE TECHNOLOGIES LLC — $96.6M
- TWO SIGMA INVESTMENTS, LP — $96.3M
Members of Congress trading GMAB
- Jan 16, 2025: Josh Gottheimer bought $1.00K–$15.0K
- Dec 16, 2024: Josh Gottheimer sold $1.00K–$15.0K
- Jul 19, 2024: Josh Gottheimer bought $1.00K–$15.0K
- Jun 18, 2024: Josh Gottheimer sold $1.00K–$15.0K
5%+ owners
- Darwin Global Management, Ltd.: 5.9% (Schedule 13G, filed Oct 5, 2026)